cytochrome-c-t has been researched along with Vestibular-Diseases* in 3 studies
3 other study(ies) available for cytochrome-c-t and Vestibular-Diseases
Article | Year |
---|---|
Interconnecting pancreatic ducts: unique ductogenesis in a patient with Kabuki syndrome and cytochrome C deficiency.
Topics: Abnormalities, Multiple; Cytochromes c; Face; Hematologic Diseases; Humans; Pancreatic Ducts; Vestibular Diseases | 2021 |
Red ginseng delays age-related hearing and vestibular dysfunction in C57BL/6 mice.
Since Korean red ginseng (KRG) has been proven to protect against gentamicin-induced vestibular and hearing dysfunction, the effects of KRG on age-related inner ear disorder in C57BL/6 mice were investigated. While age-related hearing loss was detected at the age of 6months (32kHz) and 9months (16kHz) in the control group, it was significantly delayed (p<0.05) in the 150mg/kg KRG-treated group. Vestibular dysfunction was observed in the tail-hanging and swimming tests, with significantly different severity scores and swimming times detected between the control and 150mg/kg KRG-treated group at the age of 12months (p<0.05). Mice treated with 500mg/kg KRG exhibited irritability and aggravated inner ear dysfunction. Histological observation supported the findings of hearing and vestibular function defects. In conclusion, C57BL/6 mice showed early-onset hearing loss and progressive vestibular dysfunction with aging, which were delayed by treatment with 150mg/kg KRG. However, 500mg/kg KRG treatment may induce aggressive behavior. Topics: Aging; Animals; bcl-X Protein; Cytochromes c; Drug Evaluation, Preclinical; Hair Cells, Auditory; Hearing Loss; Male; Medicine, Korean Traditional; Mice, Inbred C57BL; Panax; Phytotherapy; Plant Extracts; Random Allocation; Vestibular Diseases | 2014 |
Red ginseng protects against gentamicin-induced balance dysfunction and hearing loss in rats through antiapoptotic functions of ginsenoside Rb1.
The authors evaluated the protective effects of Korean red ginseng (KRG) against gentamicin (GM)-induced unilateral vestibular and hearing dysfunction and investigated its effective mechanism using in vitro cell cultures. Vestibular function was comprehensively evaluated by a scoring system that ranged from 0 (normal) to 3 (worst) points, using head tilt, tail hanging, and swimming tests. The GM group showed significantly more deteriorated vestibular function (0 point--5 rats, 1 point--1 rat, 2 points--3 rats, and 3 points--3 rats) than the KRG+GM group (0 point--9 rats and 1 point--1 rat) (p<0.01). The hearing thresholds were better in the KRG+GM group than in the GM group (p<0.05). Quantitative analysis of hair cell damage in the scanning electron microscopy was closely related with vestibular and hearing functional results. In vitro study showed that ginsenoside Rb1 (gRb1) attenuated reactive oxygen species production, suppressed JNK activation, up-regulated Bcl-xL and down-regulated Bax, cytochrome c, caspase 3, and cleaved poly (ADP-ribose) polymerase in GM-treated VOT-E36 cells. These findings suggest that KRG including gRb1 component protects against vestibular/hearing dysfunction by inhibiting apoptotic pathways when ototoxicity is induced by unilateral intratympanic injection with GM in rats. Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line; Cytochromes c; Down-Regulation; Female; Gentamicins; Ginsenosides; Hearing Loss; Panax; Plant Extracts; Postural Balance; Protective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Up-Regulation; Vestibular Diseases | 2013 |